Federal Analogue Act (FAA)

21 USC 813; a provision of the US Controlled Substances Act declaring substances 'substantially similar' in structure or pharmacology to Schedule I or II drugs to be treated as Schedule I when intended for human consumption. Requires structural/pharmacological expert testimony and proof of consumption intent.